Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma
- PMID: 19551889
- PMCID: PMC2811690
- DOI: 10.1002/cncr.24495
Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma
Abstract
Background: Yes-associated protein (YAP), a downstream target of the Hippo signaling pathway, was recently linked to hepatocarcinogenesis in a mouse hepatocellular carcinoma (HCC) model. The objective of the current study was to investigate the clinical significance of YAP in HCC and its prognostic values in predicting survival and tumor recurrence.
Methods: The authors collected 177 pairs of tumor and adjacent nontumor tissue from HCC patients with definitive clinicopathologic and follow-up data. YAP expression was determined by immunohistochemistry, Western blot analysis, and quantitative polymerase chain reaction. Association of YAP with each clinicopathologic feature was analyzed by Pearson chi-square test, and HCC-specific disease-free survival and overall survival by Kaplan-Meier curves and log-rank test. Multivariate Cox regression analyses of YAP in HCC were also performed.
Results: YAP was expressed in the majority of HCC cases (approximately 62%) and mainly accumulated in the tumor nucleus. Overexpression of YAP in HCC was significantly associated with poorer tumor differentiation (Edmonson grade; P = .021) and high serum alpha-fetoprotein (AFP) level (P < .001). Kaplan-Meier and Cox regression data indicated that YAP was an independent predictor for HCC-specific disease-free survival (hazards ratio [HR], 1.653; 95% confidence interval [95% CI], 1.081-2.528 [P = .02]) and overall survival (HR, 2.148; 95% CI, 1.255-3.677 [P = .005]).
Conclusions: YAP is an independent prognostic marker for overall survival and disease-free survival times of HCC patients and clinicopathologically associated with tumor differentiation and serum AFP level. It is a potential therapeutic target for this aggressive malignancy.
2009 American Cancer Society.
Figures
![FIGURE 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2811690/bin/nihms-163254-f0001.gif)
![FIGURE 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2811690/bin/nihms-163254-f0002.gif)
![FIGURE 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2811690/bin/nihms-163254-f0003.gif)
Similar articles
-
Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.World J Gastroenterol. 2015 Jun 7;21(21):6649-59. doi: 10.3748/wjg.v21.i21.6649. World J Gastroenterol. 2015. PMID: 26074703 Free PMC article.
-
Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma.J Immunol Res. 2014;2014:261365. doi: 10.1155/2014/261365. Epub 2014 Apr 22. J Immunol Res. 2014. PMID: 24860833 Free PMC article.
-
Yes-associated protein expression is a predictive marker for recurrence of hepatocellular carcinoma after liver transplantation.Dig Surg. 2014;31(6):468-78. doi: 10.1159/000370252. Epub 2015 Jan 22. Dig Surg. 2014. PMID: 25632982
-
Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma.BMC Cancer. 2019 Jun 4;19(1):538. doi: 10.1186/s12885-019-5747-5. BMC Cancer. 2019. PMID: 31164099 Free PMC article.
-
YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role.Int J Mol Sci. 2019 Feb 1;20(3):638. doi: 10.3390/ijms20030638. Int J Mol Sci. 2019. PMID: 30717258 Free PMC article.
Cited by
-
Immunohistochemical evaluation of yes-associated protein molecule in the odontogenic epithelium of different histopathological variants of ameloblastoma and unicystic ameloblastoma.J Oral Maxillofac Pathol. 2024 Jan-Mar;28(1):49-55. doi: 10.4103/jomfp.jomfp_215_23. Epub 2024 Apr 15. J Oral Maxillofac Pathol. 2024. PMID: 38800449 Free PMC article.
-
Fatty acid binding protein 5 suppression attenuates obesity-induced hepatocellular carcinoma by promoting ferroptosis and intratumoral immune rewiring.Nat Metab. 2024 Apr;6(4):741-763. doi: 10.1038/s42255-024-01019-6. Epub 2024 Apr 25. Nat Metab. 2024. PMID: 38664583
-
TM4SF19 controls GABP-dependent YAP transcription in head and neck cancer under oxidative stress conditions.Proc Natl Acad Sci U S A. 2024 Feb 13;121(7):e2314346121. doi: 10.1073/pnas.2314346121. Epub 2024 Feb 5. Proc Natl Acad Sci U S A. 2024. PMID: 38315837
-
The circadian clock protein Cryptochrome 1 is a direct target and feedback regulator of the Hippo pathway.iScience. 2023 Jul 20;26(8):107449. doi: 10.1016/j.isci.2023.107449. eCollection 2023 Aug 18. iScience. 2023. PMID: 37593458 Free PMC article.
-
Yes-associated protein-1 overexpression in ocular surface squamous neoplasia; a potential diagnostic marker and therapeutic target.Front Oncol. 2023 Jul 5;13:1213426. doi: 10.3389/fonc.2023.1213426. eCollection 2023. Front Oncol. 2023. PMID: 37476371 Free PMC article.
References
-
- Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across 5 continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–2150. - PubMed
-
- Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55:10–30. - PubMed
-
- Yu MC, Yuan JM. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology. 2004;127(5 suppl 1):S72–S78. - PubMed
-
- El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002;35(5 suppl 2):S72–S781. - PubMed
-
- Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical